• Iván Alvarez-Twose, Roberta Zanotti, David González-de-Olano, Patrizia Bonadonna, Arantza Vega, Almudena Matito, Laura Sánchez-Muñoz, José Mário Morgado, Omar Perbellini, Andrés García-Montero, Giovanna De Matteis, Cristina Teodósio, Maurizio Rossini, María Jara-Acevedo, Donatella Schena, Andrea Mayado, Alberto Zamò, Manuela Mollejo, Paula Sánchez-López, Nieves Cabañes, Alberto Orfao, Luis Escribano, Spanish Network on Mastocytosis (REMA), and Italian Network on Mastocytosis (RIMA).
• Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain. Electronic address: ivana@sescam.jccm.es.
• J. Allergy Clin. Immunol. 2014 Feb 1; 133 (2): 520-8.

BackgroundIndolent systemic mastocytosis (ISM) without skin lesions (ISMs(-)) shows a higher prevalence in males, lower serum baseline tryptase levels, and KIT mutation more frequently restricted to bone marrow (BM) mast cells (MCs) than ISM with skin lesions (ISMs(+)). Interestingly, in almost one-half of ISMs(-) patients, MC-mediator release episodes are triggered exclusively by insects.ObjectiveWe aimed to determine the clinical and laboratory features of ISMs(-) associated with insect-induced anaphylaxis (insectISMs(-)) versus other patients with ISM.MethodsA total of 335 patients presenting with MC activation syndrome, including 143 insectISMs(-), 72 ISMs(-) triggered by other factors (otherISMs(-)), 56 ISMs(+), and 64 nonclonal MC activation syndrome, were studied.ResultsCompared with otherISMs(-) and ISMs(+) patients, insectISMs(-) cases showed marked male predominance (78% vs 53% and 46%; P < .001), a distinct pattern of MC-related symptoms, and significantly lower median serum baseline tryptase levels (22.4 vs 28.7 and 45.8 μg/L; P ≤ .009). Moreover, insectISMs(-) less frequently presented BM MC aggregates (46% vs 70% and 81%; P ≤ .001), and they systematically showed MC-restricted KIT mutation.ConclusionsISMs(-) patients with anaphylaxis triggered exclusively by insects display clinical and laboratory features that are significantly different from other ISM cases, including other ISMs(-) and ISMs(+) patients, suggesting that they represent a unique subgroup of ISM with a particularly low BM MC burden in the absence of adverse prognostic factors.Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

47 keywords...

hide…